High serum levels of menatetrenone in male patients with ossification of the posterior longitudinal ligament

Spine

Volumn 28, Issue 16, 2003, Pages 1789-1793

  Yamada, Kenji ^a   Inui, Kentaro ^a   Iwamoto, Masahiro ^b   Nakamura, Hiroaki ^a   Tsujio, Tadao ^a   Konishi, Sadahiko ^a   Ito, Yoichi ^a   Takaoka, Kunio ^a   Koike, Tatsuya ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Alkaline phosphatase; Cell culture; Ossification of posterior longitudinal ligament; Osteocalcin; Vitamin K

Indexed keywords

ALKALINE PHOSPHATASE; MENATETRENONE; OSTEOCALCIN; VITAMIN K GROUP;

ADULT; AGED; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HYPEROSTOSIS; LIGAMENT CALCINOSIS; MALE; PATHOGENESIS; PRIORITY JOURNAL;

AGED; ALKALINE PHOSPHATASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LONGITUDINAL LIGAMENTS; MALE; MIDDLE AGED; OSSIFICATION OF POSTERIOR LONGITUDINAL LIGAMENT; OSTEOCALCIN; SEX FACTORS; TIME FACTORS; VITAMIN K 2;

EID: 0042474439     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.BRS.0000084664.88303.B8     Document Type: Article

References (36)

1. Gundberg CM, Nieman SD, Abrams S, et al. Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab 1998;83:3258-66.
2. Liu G. Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Calcif Tissue Int 1998;62:286-289.
3. Yagami K, Enomoto-Iwamoto M, Koyama E, et al. Matrix GLA protein is a developmental regulator of chondrocyte mineralization and, when constitutively expressed, blocks endochondral and intramembranous ossification in the limb. J Cell Biol 1999;145:1097-1108.
4. Binkley NC, Krueger DC, Engelke JA, et al. Vitamin K supplementation reduces serum concentrations of under-gamma-carboxylated osteocalcin in healthy young and elderly adults. Am J Clin Nutr 2000;72:1523-1528.
5. Luo G, Ducy P, McKee, MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997;386:78-81.
6. Shanahan CM, Proudfoot D, Farzaneh-Far A, et al. The role of Gla-proteins in vascular calcification. Crit Rev Eukar Gene Expr 1998;8:357-375.
7. Terayama K. Genetic studies on ossification of the posterior longitudinal ligament of the spine. Spine 1989;14:1184-1191.
8. Hamanishi C, Tan A, Yamane T, et al. Ossification of the posterior longitudinal ligament. Autosomal recessive trait. Spine 1995;20:205-207.
9. Koga H, Sakou T, Taketomi E, et al. Genetic mapping of ossification of the posterior longitudinal ligament of the spine. Am J Hum Genet 1998;62:1460-1467.
10. Okawa A, Nakamura I, Goto S, et al. Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat Genet 1998;19:271-273.
11. Matsunaga S, Yamaguchi M, Hayashi K, et al. Genetic analysis of ossification of the posterior longitudinal ligament. Spine 1999;24:937-938.
12. Nakamura I, Ikegawa S, Okawa A, et al. Association of the human NPPS gene with ossification of the posterior longitudinal ligament of the spine (OPLL). Hum Genet 1999;104:492-497.
13. Numasawa T, Koga H, Ueyama K, et al. Human retinoic X receptor beta: complete genomic sequence and mutation search for ossification of posterior longitudinal ligament of the spine. J Bone Miner Res 1999;14:500-508.
14. Hirai N, Ikata T, Murase M, et al. Bone mineral density of the lumbar spine in patients with ossification of the posterior longitudinal ligament of the cervical spine. J Spinal Disord 1995;8:337-341.
15. Yamauchi T, Taketomi E, Matsunaga S, et al. Bone mineral density in patients with ossification of the posterior longitudinal ligament in the cervical spine. J Bone Miner Metab 1999;17:296-300.
16. Morio Y, Yamamoto K, Kishimoto H, et al. Bone mineral density of the radius in patients with ossification of the cervical posterior ligament- A longitudinal study. Spine 1993;18:2513-2516.
17. Nakamura K, Hoshino Y, Saito K, et al. Bone mineral density in patients with ossification of the posterior longitudinal ligament. Minimal decrease of bone mineral density with aging. Spine 1997;22:2388-2392.
18. Matsui H, Yudoh K, Tsuji H. Significance of serum levels of type I procollagen peptide and intact osteocalcin and bone mineral density in patients with ossification of the posterior longitudinal ligaments. Calcif Tissue Int 1996;59:397-400.
19. Kodama T, Matsunaga S, Taketomi E, et al. Retinoid and bone metabolic marker in ossification of the posterior longitudinal ligament. In Vivo 1998;12:339-344.
20. Ishihara C, Kushida K, Takahashi M, et al. The efficacy of biochemical markers in patients with ossification of posterior longitudinal ligament of the spine. Spinal Cord 2000;38:211-213.
21. Inaba K, Matsunaga S, Ishidou Y, et al. Effect of transforming growth factor-beta on fibroblasts in ossification of the posterior longitudinal ligament. In Vivo 1996;10:445-449.
22. Kon T, Yamazaki M, Tagawa M, et al. Bone morphogenetic protein-2 stimulates differentiation of cultured spinal ligament cells from patients with ossification of the posterior longitudinal ligament. Calcif Tissue Int 1997;60:291-296.
23. Sakou T, Matsunaga S, Koga H. Recent progress in the study of pathogenesis of ossification of the posterior longitudinal ligament. J Orthop Sci 2000;5:310-315.
24. Benjamin M, Rufai A, Ralphs JR. The mechanism of formation of bony spurs (enthesophytes) in the achilles tendon. Arthritis Rheum 2000;43:576-583.
25. Wang PN, Chen SS, Liu HC, et al. Ossification of the posterior longitudinal ligament of the spine. A case-control risk factor study. Spine 1999;24:142-144.
26. Dam H. The antihaemorrhagic vitamin in the chick. Biochem J 1935;29:1273-1285.
27. Vermeer C, Schurgers LJ. A comprehensive review of vitamin K and vitamin K antagonists. Hematol Oncol Clin North Am 2000;14:339-353.
28. Douglas AS, Robins SP, Hutchison JD, et al. Carboxylation of osteocalcin in post-menopausal osteoporotic women following vitamin K and D supplementation. Bone 1995;17:15-20.
29. Shiraki M, Shiraki Y, Aoki C, et al. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 2000;15:515-521.
30. Koshihara Y, Hoshi K. Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res 1997;12:431-438.
31. Takeuchi Y, Suzawa M, Fukumoto S, et al. Vitamin K(2) inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures. Bone 2000;27:769-776.
32. Urayama S, Kawakami A, Nakashima T, et al. Effect of vitamin K2 on osteoblast apoptosis: vitamin K2 inhibits apoptotic cell death of human osteoblasts induced by Fas, proteasome inhibitor, etoposide, and staurosporine. J Lab Clin Med 2000;136:181-193.
33. Kaneki M, Hedges SJ, Hosoi T, et al. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk. Nutrition 2001;17:315-321.
34. Sato Y, Honda Y, Kuno H, et al. Menatetrenone ameliorates osteopenia in disuse-effected limbs of vitamin D- and K- deficient stroke patients. Bone 1998;23:291-296.
35. Pacifici M, Golden EB, Iwamoto M, et al. Retinoic acid treatment induces type X collagen gene expression in cultured chick chondrocytes. Exp cell Res 1991;195:38-46.
36. Goro K, Yamazaki M, Tagawa M, et al. Involvement of insulin-like growth factor I in development of ossification of the posterior longitudinal ligament of the spine. Calcif Tissue Int 1998;62:158-165.